Biosensor Platform Leverages Silicon Semiconductor Manufacturing for Scale

生物传感器平台利用硅半导体制造进行规模化

Technology Designed to Provide a Better View of Metabolic Health by Combining Glucose Information with Context Around Activities of Daily Living in One Device

通过在一台设备中将葡萄糖信息与日常生活活动的背景相结合，旨在更好地了解代谢健康的技术

$58 Million in Funding Led by Alpha Wave Ventures

由Alpha Wave Ventures牵头的5800万美元资金

Biolinq Incorporated, a healthcare technology company pioneering precision multi-analyte biosensors to improve metabolic health, today announced the completion of $58 million in financing led by Alpha Wave Ventures, with participation from Niterra’s corporate venture capital fund jointly operated with Pegasus Tech Ventures and existing investors RiverVest Venture Partners, AXA IM Alts, Global Health Investment Corporation, Aphelion Capital, Senvest Management, Features Capital, and Taisho Pharmaceutical.

Biolinq Incorporated是一家开创精密多分析物生物传感器以改善代谢健康的医疗技术公司，今天宣布完成由Alpha Wave Ventures牵头的5800万美元融资，Niterra的企业风险投资基金与Pegasus Tech Ventures和现有投资者RiverVest venture Partners，AXA IM Alts，Global health Investment Corporation，Aphelion capital，Senvest Management，Features capital和大正制药共同运营。

J.P. Morgan served as a placement agent to Biolinq in connection with the financing..

J、 P.Morgan担任Biolinq的配售代理，负责融资。。

The financing will support completion of a U.S. pivotal clinical trial this year, evaluating Biolinq’s proprietary intradermal glucose sensor, and subsequent FDA submission. Designed for simplicity, Biolinq’s wearable patch uses an array of tiny electrochemical sensors to measure glucose levels from the intradermal space just beneath the surface of the skin, combining glucose information with relative levels of activity in one device..

这笔资金将支持今年完成一项美国关键临床试验，评估Biolinq专有的皮内葡萄糖传感器，并随后提交FDA。为了简单起见，Biolinq的可穿戴贴片使用了一系列微型电化学传感器来测量皮肤表面下方皮内空间的葡萄糖水平，将葡萄糖信息与一个设备中的相对活性水平相结合。。

“Our technology approach enables access to a coveted, metabolically active compartment of the skin for biosensing without the use of introducer needles or bleeding,” said Rich Yang, CEO at Biolinq. “Over the past decade, our team has been pioneering a new biosensor platform designed to inform and inspire, with a mission to reach more people that are in need of simple solutions to improve metabolic health.”.

Biolinq首席执行官Rich Yang表示：“我们的技术方法能够进入令人垂涎的代谢活跃的皮肤区域进行生物传感，而无需使用引导针或出血。”。“在过去的十年中，我们的团队一直在开创一个新的生物传感器平台，旨在提供信息和启发，其使命是接触更多需要简单解决方案来改善代谢健康的人。”。

Biolinq’s wearable patch, placed on the upper forearm with a clear line of sight, incorporates an intuitive display on the device that informs users when glucose levels are within a target range and when glucose levels are elevated beyond a healthy range. Biolinq’s array of sensors on a silicon chip are designed for redundancy, reliability, and multi-analyte capabilities..

Biolinq的可穿戴贴片位于前臂上部，视线清晰，在设备上有一个直观的显示，可以在血糖水平在目标范围内以及血糖水平升高超过健康范围时通知用户。Biolinq在硅芯片上的传感器阵列设计用于冗余、可靠性和多分析物功能。。

“Companies that disrupt entire industries often don’t originate from a single discipline,” said Rick Gerson, Chairman at Alpha Wave Global. “Biolinq has attracted leading experts in biosensor development, consumer electronics design, proprietary materials science, software engineering, and semiconductor manufacturing to build a new category of biowearables.

Alpha Wave Global董事长里克·格森（RickGerson）表示：“扰乱整个行业的公司往往不是来自单一学科。”。“Biolinq吸引了生物传感器开发、消费电子设计、专有材料科学、软件工程和半导体制造等领域的顶尖专家，打造了一类新的生物可穿戴设备。

Biolinq is well-positioned to enter the market with a differentiated solution for people living with diabetes.”.

Biolinq凭借针对糖尿病患者的差异化解决方案进入市场。”。

“Biolinq’s technology enables a new era for self-monitoring, with a product platform designed to make continuous sensing simple and more accessible,” said Dan Bradbury, Chairman at Biolinq. “We have a meaningful opportunity to transform care delivery and enable healthier living by opening up a new frontier in continuous sensing.”.

Biolinq董事长丹·布拉德伯里（DanBradbury）表示：“Biolinq的技术开创了自我监测的新时代，其产品平台旨在使连续传感变得简单且更容易获得。”。“我们有一个有意义的机会来改变护理服务，并通过开辟持续感知的新领域来实现更健康的生活。”。

Biolinq’s intradermal glucose sensor is an investigational device that is not yet cleared or approved by the FDA or any other regulatory authority.

Biolinq的皮内葡萄糖传感器是一种研究设备，尚未获得FDA或任何其他监管机构的批准或批准。

About Biolinq

关于Biolinq

Biolinq is a healthcare technology company pioneering precision multi-analyte wearable sensors to improve metabolic health. The company’s biosensor platform is designed to inform and inspire with unparalleled simplicity to support healthier living. With microsensors that reside just below the skin’s surface, Biolinq is redefining the future of continuous small molecule biosensing.

Biolinq是一家医疗保健技术公司，开创了精密多分析物可穿戴传感器的先河，以改善代谢健康。该公司的生物传感器平台旨在以无与伦比的简单性提供信息并激发灵感，以支持更健康的生活。由于微传感器位于皮肤表面下方，Biolinq正在重新定义连续小分子生物传感的未来。

The company is headquartered in San Diego, CA. For more information, please visit biolinq.com..

该公司总部位于加利福尼亚州圣地亚哥。有关更多信息，请访问biolinq.com。。

About Alpha Wave

关于Alpha Wave

Alpha Wave is a global investment company with three main verticals: private equity, private credit, and public markets. It is led by Rick Gerson, Navroz Udwadia, and Ryan Khoury. Its flagship global private equity fund, Alpha Wave Ventures, aims to invest in best-in-class growth-stage companies and endeavors to be helpful long-term partners to the founders and management teams..

Alpha Wave是一家全球性投资公司，拥有三大垂直领域：私募股权、私人信贷和公共市场。它由里克·格森、纳夫罗兹·乌德瓦迪亚和瑞安·霍里领导。其旗舰全球私募股权基金Alpha Wave Ventures旨在投资一流的成长阶段公司，并努力成为创始人和管理团队的长期合作伙伴。。

Alpha Wave has offices in New York, Miami, London, Monaco, Madrid, Abu Dhabi, Tel Aviv, Bangalore, and Sydney. For more information, please visit alphawaveglobal.com.

Alpha Wave在纽约、迈阿密、伦敦、摩纳哥、马德里、阿布扎比、特拉维夫、班加罗尔和悉尼设有办事处。有关更多信息，请访问alphawaveglobal.com。

Originally announced April 4th, 2024

最初于2024年4月4日宣布

TagsAlpha Wave Ventures Aphelion Capital AXA IM Alts Biolinq Biolinq Incorporated Dan Bradbury Features Capital Global Health Investment Corporation Health IT Funding Health IT Fundings Health IT Investment J.P. Morgan Niterra Pegasus Tech Ventures Rich Yang Rick Gerson RiverVest Venture Partners Senvest Management Taisho Pharmaceutical .

TagsAlpha Wave Ventures Aphelion Capital AXA IM Alts Biolinq Biolinq Incorporated Dan Bradbury Features Capital Global Health Investment Corporation Health IT Funding Health IT Fundings Health IT Investment J.P.Morgan Niterra Pegasus Tech Ventures Rich Yang Rick Gerson RiverVest Vest Venture Partners Senvest Management大正制药公司。

Get Fresh Healthcare & IT Stories Delivered Daily

每天提供新鲜的医疗保健和IT故事

Join thousands of your healthcare & HealthIT peers who subscribe to our daily newsletter.

加入成千上万订阅我们每日新闻稿的healthcare&HealthIT同行。

We respect your privacy and will never sell or give out your contact information

我们尊重您的隐私，绝不出售或泄露您的联系信息